Yaz Blood Clots Mean Settlements for Some Patients

One of the most serious Yaz side effects of the popular fourth-generation brand of birth control marketed  is the potential for patients to experience Yaz blood clots, which can sometimes manifest in the lungs as pulmonary embolisms. Because these Yaz birth control side effects are so serious and potentially life-threatening, many patients who have experienced them are filing a Yaz lawsuit against the drugmaker, Bayer, in order to gain some compensation for the medical costs and other drains on finances and quality of life associated with the condition.

            It may leave a Yaz lawyer wondering about the possibility that Bayer might choose to settle with some plaintiffs out of court. This would be beneficial to both parties as details of the settlement and the case could be
kept confidential, while the money would be received more quickly by the plaintiff, who could then start paying

off medical bills and other costs. This way could also help diminish lengthy court battles, which often become bitter and sensationalized in the media, often with the drugmaker being portrayed as a cruel and destructive corporate giant with no regard for the health of individuals. However, Bayer has shown no signs of wanting to avoid such a battle.

            The drugmaker, one of the largest in the country, has indicated that they do not, at this time, have any plans related to out-of-court settlements. However, legal experts and Yaz lawyers believe that this stance could change as preliminary bellwether trials are approaching. There are more than 7,000 lawsuits currently pending in the court system surrounding Yaz birth control side effects and the similar birth control pill Yasmin side effects, which is also manufactured by Bayer. The number of settlements Bayer would need to hand out should they choose to go that route could be up to 25,000, a staggering number of patients who have experienced side effects, such as yaz and yasmin blood clots from one of the most popular forms of birth control in the country.

            Studies have already linked Yaz and Yasmin, as well as other drospirenone-based birth control pills, with an elevated risk of developing potentially fatal blood clots. These studies could be a nail in Bayer’s coffin in upcoming Yaz trials.